Effect of lipid-polymer hybrid nanoparticles on the biophysical function and lateral structure of pulmonary surfactant: Mechanistic in vitro studies
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Effect of lipid-polymer hybrid nanoparticles on the biophysical function and lateral structure of pulmonary surfactant : Mechanistic in vitro studies. / Xu, You; Cañadas, Olga; Alonso, Alejandro; Franzyk, Henrik; Thakur, Aneesh; Pérez-gil, Jesús; Foged, Camilla.
In: Journal of Colloid and Interface Science, Vol. 654, No. Part B, 2024, p. 1111-1123.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Effect of lipid-polymer hybrid nanoparticles on the biophysical function and lateral structure of pulmonary surfactant
T2 - Mechanistic in vitro studies
AU - Xu, You
AU - Cañadas, Olga
AU - Alonso, Alejandro
AU - Franzyk, Henrik
AU - Thakur, Aneesh
AU - Pérez-gil, Jesús
AU - Foged, Camilla
N1 - Funding Information: We gratefully acknowledge the financial support from the Novo Nordisk Foundation, Denmark (grant no. NNF17OC0026526), Independent Research Fund, Denmark (grant no. DFF-4184-00422), the regional Government of Madrid (grant no. P2018/NMT4389), and the Spanish Ministry of Science and Innovation (grant no. PID2021-124932OB-I00). We acknowledge the China Scholarship Council (CSC) for the Scholarship to You Xu (grant no. 201906210064). Funding Information: We thank Abhijeet Girish Lokras and Akash Chakravarty for purifying L5N12. We thank Paula Losada for helping with the graphical abstract. Publisher Copyright: © 2023 Elsevier Inc.
PY - 2024
Y1 - 2024
N2 - The interaction between inhaled drug-loaded nanoparticles and pulmonary surfactant (PS) is critical for the efficacy and safety of inhaled nanomedicines. Here, we investigated the effect of small interfering RNA (siRNA)-loaded lipid-polymer hybrid nanoparticles (LPNs), which are designed for treatment of lung inflammation, on the physiological function of PS. By using biophysical in vitro methods we show that siRNA-loaded LPNs affect the biophysical function and lateral structure of PS. We used the Langmuir monolayer technique to demonstrate that LPNs display intrinsic surface activity by forming interfacial films that collapse at 49 mN/m, and they competitively inhibit the adsorption and spreading of PS components at the air–liquid interface. However, LPNs are excluded from the interface into the aqueous subphase at surface pressures above 49 mN/m, and hence they overcome the PS monolayer film barrier. Epifluorescence microscopy data revealed that LPNs influence the lateral structure of PS by: (i) affecting the nucleation, shape, and growth of compression-driven segregated condensed PS domains, and (ii) facilitating intermixing of liquid-expanded and tilted-condensed domains. However, the total surface area occupied by a highly condensed phase, presumably enriched in the highly surface tension-reducing dipalmitoylphosphatidylcholine, remained constant upon exposure to LPNs. These results suggest that surface-active LPNs influence the lateral structure of PS during translocation from the interface into the subphase, but LPNs do apparently not affect the biophysical function of PS under physiologically relevant conditions.
AB - The interaction between inhaled drug-loaded nanoparticles and pulmonary surfactant (PS) is critical for the efficacy and safety of inhaled nanomedicines. Here, we investigated the effect of small interfering RNA (siRNA)-loaded lipid-polymer hybrid nanoparticles (LPNs), which are designed for treatment of lung inflammation, on the physiological function of PS. By using biophysical in vitro methods we show that siRNA-loaded LPNs affect the biophysical function and lateral structure of PS. We used the Langmuir monolayer technique to demonstrate that LPNs display intrinsic surface activity by forming interfacial films that collapse at 49 mN/m, and they competitively inhibit the adsorption and spreading of PS components at the air–liquid interface. However, LPNs are excluded from the interface into the aqueous subphase at surface pressures above 49 mN/m, and hence they overcome the PS monolayer film barrier. Epifluorescence microscopy data revealed that LPNs influence the lateral structure of PS by: (i) affecting the nucleation, shape, and growth of compression-driven segregated condensed PS domains, and (ii) facilitating intermixing of liquid-expanded and tilted-condensed domains. However, the total surface area occupied by a highly condensed phase, presumably enriched in the highly surface tension-reducing dipalmitoylphosphatidylcholine, remained constant upon exposure to LPNs. These results suggest that surface-active LPNs influence the lateral structure of PS during translocation from the interface into the subphase, but LPNs do apparently not affect the biophysical function of PS under physiologically relevant conditions.
KW - Air–liquid interface
KW - Biophysical function
KW - Interfacial adsorption
KW - Lateral structure
KW - Nanoparticle translocation
KW - Pulmonary drug delivery
KW - Surface activity
U2 - 10.1016/j.jcis.2023.10.036
DO - 10.1016/j.jcis.2023.10.036
M3 - Journal article
VL - 654
SP - 1111
EP - 1123
JO - Journal of Colloid and Interface Science
JF - Journal of Colloid and Interface Science
SN - 0021-9797
IS - Part B
ER -
ID: 369917460